저항전분 관련 장누수증후군(장 투과성 증가)
C 근거 소규모 연구에서의 근거는 제한적이지만, 일부 긍정적인 신호가 존재합니다.가장 강력한 부티레이트 생성 프리바이오틱입니다. 대변 부티레이트 농도를 30~40% 증가시킵니다. 장벽 기능에 대한 임상적 의의는 더 많은 RCT가 필요합니다.
결론
가장 강력한 부티레이트 생성 프리바이오틱입니다. 대변 부티레이트 농도를 30~40% 증가시킵니다. 장벽 기능에 대한 임상적 의의는 더 많은 RCT가 필요합니다.
Key Study Findings
대상 집단: narrative review of gut microbiota role in IBS pathophysiology
대상 집단: OVA-induced food allergy mouse model
대상 집단: NAFLD mouse model (HFD + DSS induced)
대상 집단: in vivo animal models (preclinical)
대상 집단: Meat ducklings with antibiotic-induced bone loss
대상 집단: Mouse model
Key Statistics
4
연구
300
참여자
Positive
등급
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 15-30 g/day
- guthealthsupport:
- 20-40 g/day (titrate up gradually over 2-4 weeks)
상한량: Well-tolerated up to 45 g/day when titrated gradually
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Neutral | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | 10 |
| 12.5% resistant starch diet | 10 weeks | Positive | -- |
권장 복용 시간: With meals; start with small amount (5 g/day) and increase gradually
Safety & Side Effects
보고된 부작용
- ⚠ Gas and bloating (common initially; typically resolves in 2-4 weeks)
- ⚠ Flatulence (more pronounced than other prebiotics)
- ⚠ Abdominal discomfort during adaptation period
- ⚠ Loose stools if introduced too quickly
알려진 상호작용
- ● Blood sugar-lowering medications (resistant starch may improve insulin sensitivity)
- ● Other high-fiber foods (cumulative fermentation effect)
일일 최대 섭취 허용량: Well-tolerated up to 45 g/day when titrated gradually
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 저항전분 help with 장누수증후군(장 투과성 증가)?
How much 저항전분 should I take for 장누수증후군(장 투과성 증가)?
Are there side effects of 저항전분?
How strong is the evidence for 저항전분 and 장누수증후군(장 투과성 증가)?
Related Evidence
저항전분 다른 건강 상태에 대한 근거
References
- [1] Vinícius Parzanini Brilhante de São José et al.. Crit Rev Food Sci Nutr. 2026. Preclinical evidence on the impact of sorghum (Sorghum bicolor) genotypes, fractions, and processing methods on intestinal health: a review of … doi:10.1080/10408398.2025.2556229 PubMed
- [2] Akira Andoh et al.. Digestion. 2026. Association between the Gut Microbiota and the Pathophysiology of Irritable Bowel Syndrome - a Narrative Review. doi:10.1159/000550907 PubMed
- [3] Xuan Li et al.. J Agric Food Chem. 2026. Lotus Seed Resistant Starch Alleviates Ovalbumin-Induced Food Allergy in Mice by Enhancing the Intestinal Barrier and Regulating SCFAs and GPRs. doi:10.1021/acs.jafc.5c13034 PubMed
- [4] Huanhuan Dong et al.. Int J Biol Macromol. 2026. Mitigative effect of natural resistant starch from kudzu on intestinal-hepatic injury in mice exposed to high-fat diet and dextran sulfate … doi:10.1016/j.ijbiomac.2026.151338 PubMed
- [5] Y Y Huang et al.. Poult Sci. 2025. The protective effects of dietary resistant starch against post-antibiotic bone loss in meat ducks associated with the recovery of caecal … doi:10.1016/j.psj.2025.105238 PubMed
- [6] Miri Park et al.. Food Res Int. 2024. Resistant starch-enriched brown rice exhibits prebiotic properties and enhances gut health in obese mice. doi:10.1016/j.foodres.2024.114417 PubMed
- [7] Lucimar Aguiar da Silva et al.. Foods. 2024. Effects of a Sorghum Beverage with Lacticaseibacillus paracasei on Body Composition, Lipid Profiles, and Intestinal Health in Overweight and Obese … doi:10.3390/foods13193128 PubMed
- [8] Matthew Snelson et al.. Nutr Diabetes. 2024. Dietary resistant starch enhances immune health of the kidney in diabetes via promoting microbially-derived metabolites and dampening neutrophil recruitment. doi:10.1038/s41387-024-00305-2 PubMed
- [9] Sisi Cao et al.. Nutrients. 2022. Daily Inclusion of Resistant Starch-Containing Potatoes in a Dietary Guidelines for Americans Dietary Pattern Does Not Adversely Affect Cardiometabolic Risk … doi:10.3390/nu14081545 PubMed
- [10] Brian J Kerr et al.. J Anim Sci. 2022. Evaluation of digestively resistant or soluble fibers, short- and medium-chain fatty acids, trace minerals, and antibiotics in nonchallenged nursery pigs … doi:10.1093/jas/skac282 PubMed
- [11] Simeng Qin et al.. J Anim Sci Biotechnol. 2022. Dietary resistant starch ameliorating lipopolysaccharide-induced inflammation in meat ducks associated with the alteration in gut microbiome and glucagon-like peptide 1 … doi:10.1186/s40104-022-00735-x PubMed
- [12] Mark F McCarty et al.. Adv Nutr. 2021. Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function. doi:10.1093/advances/nmaa139 PubMed
- [13] Yawen Zhang et al.. Aging (Albany NY). 2020. Dietary type 2 resistant starch improves systemic inflammation and intestinal permeability by modulating microbiota and metabolites in aged mice on … doi:10.18632/aging.103187 PubMed
- [14] Matthew Snelson et al.. Am J Physiol Renal Physiol. 2020. Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy. doi:10.1152/ajprenal.00505.2019 PubMed
- [15] Y A Kim et al.. Nutr Res Rev. 2018. Probiotics, prebiotics, synbiotics and insulin sensitivity. doi:10.1017/S095442241700018X PubMed
- [16] Rosica Valcheva et al.. J Nutr. 2015. Soluble Dextrin Fibers Alter the Intestinal Microbiota and Reduce Proinflammatory Cytokine Secretion in Male IL-10-Deficient Mice. doi:10.3945/jn.114.207738 PubMed
- [17] Tina Skau Nielsen et al.. J Agric Food Chem. 2015. Effects of Resistant Starch and Arabinoxylan on Parameters Related to Large Intestinal and Metabolic Health in Pigs Fed Fat-Rich Diets. doi:10.1021/acs.jafc.5b03372 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.